Following three consecutive years of unusually strong gains, the US stock market is stepping into 2026 with a note of caution. The S&P 500 delivered returns of approximately 25% in both 2023 and 2024, followed by a gain of nearly 20% in 2025. This sustained rally has pushed valuations higher, with the index now trading at about 22 times expected 2026 earnings. Many of the most compelling opportunities now appear to be stocks with strong fundamentals that have lagged in recent price performance.
While often not the most exciting investments, value stocks can provide steady capital appreciation and tend to hold up better during periods of market volatility, allowing investors to sleep more soundly. These are typically mature companies with stable revenue streams and share prices that appear attractive based on fundamental metrics such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-book (P/B) ratios. The best value stocks generally share key characteristics: attractive fundamental valuation, a healthy balance sheet, stable or growing market share within a sizable industry, and a long track record of profitability.
Here are six value stocks selected by Morningstar analysts for consideration in 2026:
PepsiCo is a global beverage and snack giant, owner of brands like Frito-Lay and Quaker. Analyst Dan Su notes that while PepsiCo’s North American snack business has lagged, he anticipates cost-cutting measures and consumer engagement initiatives will help return the division to profitable growth. He also expects further growth from Latin America, Asia, and other international markets. Given his expectations for 4% annual sales growth and 15% average operating margins over the next decade, Su believes the stock is undervalued. The company also plans to increase capital returns to shareholders.
Adobe produces software for creative content, marketing, and e-commerce. Its stock underperformed in 2025. However, analyst Romanoff points out that the company has exceeded his revenue expectations for six consecutive quarters. He views the fact that Adobe’s remaining performance obligations and annual recurring revenue have been growing faster than its total revenue as a positive indicator for 2026. Romanoff suggests the recent share price weakness represents a buying opportunity for long-term value investors and that Adobe has potential to expand its margins over the next five years.
UnitedHealth is the largest managed healthcare company in the United States, providing health plans and services to a broad customer base. Its operations include the UnitedHealthcare insurance business, the OptumRx pharmacy benefit manager, and the Optum Health integrated care delivery unit. Analyst Julie Utterback states that UnitedHealthcare’s integrated model has historically delivered impressive returns, prompting emulation by other managed care organizations. She notes the company aims for long-term annual earnings growth between 13% and 16%.
Pfizer is one of the world’s largest pharmaceutical firms with a diversified portfolio of drugs treating various conditions. Its top-selling products include the blood thinner Eliquis, cardiomyopathy treatment Vyndaqel, and pneumococcal vaccine Prevnar. Analyst Karen Andersen acknowledges that Pfizer’s overall numbers have been weighed down by declining COVID-19 product sales. However, she argues that the stock appears significantly undervalued based on its stable dividend and potential for long-term revenue growth. Andersen holds particularly high hopes for the cancer drug Padcev.
Lockheed Martin is a leading global defense, security, and intelligence contractor and a key supplier to NASA and other non-defense government agencies. The company produces missile and targeting systems, mission systems for ships, submarines, and aircraft, and manufactures Black Hawk and Seahawk military helicopters. Analyst Nicolas Owens believes investor concerns regarding the F-35 program are overblown. He emphasizes that the F-35 will remain a critical component of U.S. military operations and that Lockheed Martin will continue to be a reliable generator of free cash flow.
Following its 2020 merger with Sprint, T-Mobile is now the second-largest wireless carrier in the U.S. It has achieved consistent growth in a challenging industry, even during economic downturns. Analyst Michael Hodel notes that while T-Mobile’s pricing and margins have recently been soft, its ability to steadily gain market share is a testament to superb execution. He identifies the company’s aggressive marketing around network quality as a key catalyst and predicts steady price increases and expanding cash flow over the long term.
As markets navigate elevated valuations, these value-oriented picks highlight a potential shift towards stability and fundamentally sound opportunities in the year ahead.
